STAT+: Pharmalittle: Pfizer scraps half of participants in Lyme vaccine trial over quality issues; Ginkgo CEO may have possible conflict of interest
Pfizer discontinued a significant percentage of participants in a study testing a Lyme vaccine due to violations at trial sites run by a third party.
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about, and ). And what about you? Given the warmer temps lately, this may be a fine time to enjoy the great outdoors, but do wear your boots in case of rising sea levels. You could park yourself in front of the telly to binge-watch something or other. Or you could make time to reach out to someone special. Well, whatever you do, have a grand time. Be safe. See you on Tuesday, though. due to a holiday on this side of the pond. Meanwhile, enjoy. …
